Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 241 AL 255

Alzheimer's Disease and its Related Dementia Types: A Review on Their Management Via Nanotechnology Based Therapeutic Strategies

Siafaka PI, Mutlu G, Okur NÜ.

Curr Alzheimer Res. 2020;17(14):1239-1261. doi: 10.2174/1567205018666210218160812.

CAR (Current Alzheimer Research) has a ROAD (Research on AD) Even in the Lockdown

Lahiri DK, Farlow MR.

Curr Alzheimer Res. 2020;17(12):1053-1054. doi: 10.2174/156720501712210222105659.

Alzheimer's disease: exploring nature's 'medicinal chest' for new therapeutic agents

Tsarbopoulos A.

Biomol Concepts. 2020 Dec 23;11(1):201-208. doi: 10.1515/bmc-2020-0018.

Alzheimer's disease: A need for personalized therapeutic approaches

Frenkel D.

Drug Dev Res. 2020 Apr;81(2):141-143. doi: 10.1002/ddr.21652. Epub 2020 Mar 3.

Traditional Chinese medicine Danggui Shaoyao San for the treatment of Alzheimer's disease: A Protocol for Systematic Review

You Y, Liu X, You Y, Liu D, Zhang C, Chen Y, Zhang T.

Medicine (Baltimore). 2020 Apr;99(15):e19669. doi: 10.1097/MD.0000000000019669.

Acupuncture therapy for Alzheimer's disease: A protocol for an overview of systematic reviews

Wang L, Xu J, Zhan Y, Pei J.

Medicine (Baltimore). 2020 May 22;99(21):e20244. doi: 10.1097/MD.0000000000020244.

Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials

Hung A, Schneider M, Lopez MH, McClellan M.

J Manag Care Spec Pharm. 2020 Jul;26(7):888-900. doi: 10.18553/jmcp.2020.26.7.888.

Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach

Alavi A, Barrio JR, Werner TJ, Khosravi M, Newberg A, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):225-230. doi: 10.1007/s00259-019-04564-5.

Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease

Sabbagh M, Sadowsky C, Tousi B, Agronin ME, Alva G, Armon C, Bernick C, Keegan AP, Karantzoulis S, Baror E, Ploznik M, Pascual-Leone A.

Alzheimers Dement. 2020 Apr;16(4):641-650. doi: 10.1016/j.jalz.2019.08.197. Epub 2020 Jan 16.

An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease

Chamberlain S, Gabriel H, Strittmatter W, Didsbury J.

J Alzheimers Dis. 2020;73(3):1085-1103. doi: 10.3233/JAD-190864.

Danggui-Shaoyao-San for dementia: A PRISMA-compliant systematic review and meta-analysis

Kim Y, Cho SH.

Medicine (Baltimore). 2020 Jan;99(4):e18507. doi: 10.1097/MD.0000000000018507.

Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease

Jia J, Wei C, Chen W, Jia L, Zhou A, Wang F, Tang Y, Xu L.

J Alzheimers Dis. 2020;74(1):199-211. doi: 10.3233/JAD-190940.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias